Physicians Alliance of Connecticut

OCTOBER 18, 2024

The healthcare jobs in CT market is growing rapidly; the Bureau of Labor Statistics (BLS) projects that healthcare jobs will grow nearly 13% from 2021 to 2031, or roughly 2 million new healthcare jobs over that decade. The industry reached a three-decade high in 2023, adding more than 650,000 jobs. If you are considering healthcare jobs in CT, the Physicians Alliance of Connecticut (PACT) is a leading employer in the state.

Healthcare 52

Healthcare Healthcare Professional Patient-Centered Primary Care Physician 52

The Clinical Problem Solvers

OCTOBER 16, 2024

[link] Maddy , Youssef and Andrew share their approach to nephrotic syndrome as they discuss a case presented by Sharmin. Nephrotic Syndrome Framework To join us live on Virtual Morning Report (VMR), sign up HERE.

52

52

FDA Law Blog

OCTOBER 13, 2024

By Mark A. Tobolowsky — The Rare Pediatric Disease Priority Review Voucher program has had a bit of a tumultuous history in its 12 short years of existence. Designed to incentivize the development of drugs for pediatric rare diseases where such development may not otherwise have occurred, vouchers may be granted for drugs for serious or life-threatening rare diseases where the serious or life-threatening manifestations primarily affect individuals aged from birth to 18 years.

Government 64

Government IT Education Individual 64

PEMBlog

OCTOBER 18, 2024

Duchenne Muscular Dystrophy (DMD) is a complex and progressive disease requiring highly specialized care, especially in emergency situations. The condition affects multiple organ systems—muscular, cardiac, and respiratory—leading to a myriad of clinical complications. When patients with DMD present in the Emergency Department (ED), an understanding of the nuanced aspects of their care is essential for optimal management.

Patients 52

Patients Complication Management Consulting 52

GeriPal

OCTOBER 17, 2024

Summary Transcript CME Summary When treating heart failure, how do we distinguish between the expanding list of medications recommended for “Guideline Directed Medical Therapy” (GDMT) and what might be considered runaway polypharmacy? In this week’s podcast, we’ll tackle this crucial question, thanks to a fantastic suggestion from GeriPal listener Matthew Shuster, who will join us as a guest host.

Primary Care 113

Primary Care Patient-Centered IT Patients 113

Plum Health

OCTOBER 16, 2024

Michigan residents have been buzzing about a primary care clinic that’s setting a new standard for healthcare across the state. Whether you’re in Detroit , Corunna , Lansing , Royal Oak , or Van Buren , this clinic is offering comprehensive care that puts patient well-being first. Here’s why everyone is talking about it! Comprehensive Primary Care for Michigan Communities What sets this clinic apart is its comprehensive approach to primary care.

Clinic 52

Clinic Chronic Disease Management Primary Care Medical 52

FDA Law Blog

OCTOBER 14, 2024

By Steven J. Gonzalez — On September 27, 2024, in U.S. v. California Stem Cell Treatment Center, Inc., a Ninth Circuit panel unanimously held that a stem cell clinic’s Stromal Vascular Fraction (SVF) procedure constitutes a “drug” under the Food, Drug and Cosmetic Act (FDCA) and does not meet the “same surgical procedure” (SSP) exception to FDA’s regulation of human cells, tissues, and cellular and tissue-based products (HCT/Ps) contained in 21 C.F.R.

Clinic 59

Clinic Patient-Centered Asthma Patients 59

Adventures of a Sick Doctor

OCTOBER 12, 2024

So I left ye hanging there after my last post. Apologies. Since then, I have had six doses of Folfiri chemotherapy, one hospital admission for neutropenia (low white cell count which made me vulnerable to serious infections) and at least 14 boxes of Leonidas chocolates. I have walked 82 miles in a month for charity, because I misread the advertisement and thought it was going to be kilometres.

IT 130

IT Hospital 130

FDA Law Blog

OCTOBER 16, 2024

By Sara W. Koblitz — Further talks of the Skinny Label’s demise may be premature, as demonstrated by a new decision from the District Court for the District of Columbia upholding FDA’s interpretation of the “same labeling” provisions of the Hatch-Waxman Amendments. That is not to say that concerns about the induced infringement theory at issue in GSK v.

Manufacturing 98

Manufacturing Patients IT Hospital 98